These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7539458)

  • 1. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
    J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
    J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/APO-1 gene transfer for human malignant glioma.
    Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
    Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas.
    Shinoura N; Ohashi M; Yoshida Y; Kirino T; Asai A; Hashimoto M; Hamada H
    Cancer Gene Ther; 2000 Feb; 7(2):224-32. PubMed ID: 10770630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bcl-2 on Fas antigen-mediated cell death.
    Itoh N; Tsujimoto Y; Nagata S
    J Immunol; 1993 Jul; 151(2):621-7. PubMed ID: 7687619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
    J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
    Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
    Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: a study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell lines.
    Gazitt Y; Hu WX
    Int J Oncol; 1998 Jan; 12(1):211-20. PubMed ID: 9454907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.
    Owen-Schaub LB; Radinsky R; Kruzel E; Berry K; Yonehara S
    Cancer Res; 1994 Mar; 54(6):1580-6. PubMed ID: 7511047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.
    Mapara MY; Bargou R; Zugck C; Döhner H; Ustaoglu F; Jonker RR; Krammer PH; Dörken B
    Eur J Immunol; 1993 Mar; 23(3):702-8. PubMed ID: 7680614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.
    Roth W; Wagenknecht B; Klumpp A; Naumann U; Hahne M; Tschopp J; Weller M
    Cell Death Differ; 2001 Apr; 8(4):403-10. PubMed ID: 11550092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.
    Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
    Cancer Gene Ther; 2000 May; 7(5):732-8. PubMed ID: 10830720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
    Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W
    Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells.
    Zhu CJ; Li YB; Wong MC
    J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
    Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
    Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.